Lek's First Man Speaks up for Delo and Dnevnik
Ljubljana, 7 September - Development is one of the key elements for the future of the Ljubljana pharma stock Lek, and a partnership with Switzerland's Novartis will only strengthen it, said Lek chairman Metod Dragonja for Saturday's edition of Delo. "If the shareholders and Slovenians think that the takeover is unacceptable, they can still stop it," he added, while for another daily Dnevnik, he said that "there will be no absolute winners and no absolute losers". He also thought that the takeover cannot be compared to the brewers' war, which is a case of rivalry.
The rest of this news item is available to subscribers.
The news item consists of 1.590 characters (without spaces) or 313 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.